Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care

Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care (Optimierung Der Pharmakologischen Überleitung Von Palliativpatient:Innen Von stationär Nach Ambulant)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.

Who May Be Eligible (Plain English)

Who May Qualify: All individual indications for general and specialised palliative care as part of routine clinical practice (e.g.): - advanced, malignant tumour disease - advanced, chronic obstructive pulmonary disease - Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form Who Should NOT Join This Trial: Impossibility of understanding the information and declaration of consent. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: All individual indications for general and specialised palliative care as part of routine clinical practice (e.g.): * advanced, malignant tumour disease * advanced, chronic obstructive pulmonary disease * Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form Exclusion Criteria: Impossibility of understanding the information and declaration of consent.

Treatments Being Tested

OTHER

Structured pharmaceutical discharge management

These patients will receive structured pharmaceutical discharge management from inpatient to outpatient care.

Locations (1)

University Hospital Muenster
Münster, North Rhine-Westphalia, Germany